Source: Eur Respir J 2015; 46: E60
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
ERJ December Podcast: Management of latent Mycobacterium tuberculosis infection. Eur Respir J 2015; 46: E60

Member's Comments

No comment yet.

Related content which might interest you: Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011 ERJ July Podcast: Nontuberculous mycobacteria Source: Eur Respir J, 54 (1) 19E5401; 10.1183/13993003.E5401-2019 Year: 2019 Annual risk of infection with Mycobacterium tuberculosis Source: Eur Respir J 2005; 25: 181-185 Year: 2005 ERJ July Podcast: tuberculosis prevention and control in refugees Source: Eur Respir J 2016; 48: E67 Year: 2016 High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012) Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries Source: Eur Respir J 2015; 46: 1563-1576 Year: 2015 Management of latent Mycobacterium tuberculosis infection: WHO guidelines for countries with a low tuberculosis burden Source: International Congress 2016 – ERS publications: a focus on recent guidelines and task forces Year: 2016 Does Mycobacterium bovis appear among the clinical Mycobacterium tuberculosis complex isolates from TB patients of university hospital in Warsaw between 1999 and 2007? Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III Year: 2008 Influence of mycobacterium tuberculosis strains on recurrence of tuberculosis in Hanoi, Vietnam Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Clinical management of tuberculosis and HIV-1 co-infection Source: Eur Respir J 2010; 36: 1460-1481 Year: 2010 Pulmonary mycobacterium xenopi infection in Japan Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Mycobacterium tuberculosis susceptibility during the years 1986-2002 Source: Eur Respir J 2004; 24: Suppl. 48, 655s Year: 2004 Community acquired pneumonia due to Mycobacterium tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 416s Year: 2004 Screening for tuberculosis in patients with COVID-19 infection in Georgia. Source: Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities Year: 2021 ERJ December Podcast: Assessing the worldwide epidemiology of sarcoidosis Source: Eur Respir J 2016; 48: E72 Year: 2016 Screening for latent tuberculosis infection among healthcare workers in Bulgaria Source: Annual Congress 2009 - Tuberculosis contact screening Year: 2009 Non tuberculous mycobacteria (NTM) contamination in a hospital water supply network: Association with pulmonary infection in respiratory wards Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015 Immune response in children with latent tuberculosis infection and active pulmonary tuberculosis Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014 Mycobacterium kansasii is the main cause of respiratory infections associated with nontuberculous mycobacvteria (NTM) in patients from Department of Pneumonology of Warsaw Medical University Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007 Nontuberculous mycobacterial lung disease caused by Mycobacterium parascrofulaceum in an immunocompetent patient Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1 Year: 2014